Virios Therapeutics, Inc., listed on Nasdaq as VIRI, is a clinical-stage biotechnology company based in Alpharetta. The company specializes in developing antiviral therapies to address conditions linked to fibromyalgia.
Virios Therapeutics is dedicated to advancing innovative treatments for fibromyalgia-related ailments through its research and development efforts. With a focus on antiviral therapies, the company aims to provide effective solutions for individuals suffering from these conditions.
Generated from their website's infomation